Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 09:22 am Purchase | 2022-02-08 | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 1,978,289 7.879% | 725,903 (+57.96%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Krystal Biotech, Inc. KRYS | BlackRock Inc. BLK | 1,605,496 6.400% | 198,148 (+14.08%) | Filing History |
| 2021-12-06 5:22 pm Purchase | 2021-12-03 | 13G | Krystal Biotech, Inc. KRYS | Point72 Asset Management, L.P. | 1,343,242 5.400% | 1,343,242 (New Position) | Filing History |
| 2021-03-09 4:05 pm Unchanged | 2021-03-01 | 13G | Krystal Biotech, Inc. KRYS | Sun Pharma (Netherlands) B.V. | 914,107 4.100% | 0 (Unchanged) | Filing History |
| 2021-02-16 4:27 pm Sale | 2020-12-31 | 13G | Krystal Biotech, Inc. KRYS | BAKER BROS. ADVISORS LP | 698,874 3.500% | -335,800 (-32.45%) | Filing History |
| 2021-02-16 4:08 pm Purchase | 2020-12-31 | 13G | Krystal Biotech, Inc. KRYS | Redmile Group, LLC | 1,675,036 8.500% | 584,836 (+53.64%) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | Krystal Biotech, Inc. KRYS | T. Rowe Price Associates, Inc. | 912 0.000% | -1,049,673 (-99.91%) | Filing History |
| 2021-02-12 4:55 pm Sale | 2020-12-31 | 13G | Krystal Biotech, Inc. KRYS | ORBIMED ADVISORS LLC | 0 0.000% | -933,508 (Position Closed) | Filing History |
| 2021-02-08 10:27 am Purchase | 2021-02-05 | 13G | Krystal Biotech, Inc. KRYS | FMR LLC | 1,252,386 6.354% | 104,100 (+9.07%) | Filing History |
| 2021-02-04 4:35 pm Unchanged | 2020-12-31 | 13G | Krystal Biotech, Inc. KRYS | Frazier Life Sciences IX, L.P. | 895,000 4.500% | 0 (Unchanged) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Krystal Biotech, Inc. KRYS | BlackRock Inc. BLK | 1,407,348 7.100% | 1,407,348 (New Position) | Filing History |